ACLY Inhibition Boosts Tumor Immunity, Suppresses Liver Cancer
A groundbreaking study has unveiled a novel mechanism by which inhibiting ATP citrate lyase (ACLY) triggers a potent antitumour immune ...
A groundbreaking study has unveiled a novel mechanism by which inhibiting ATP citrate lyase (ACLY) triggers a potent antitumour immune ...
Liver cancer, specifically hepatocellular carcinoma (HCC), represents a formidable challenge in modern oncology, frequently emerging on the backdrop of chronic ...
Here are a few options, all within 8 words:
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine